Skip to Content

Division of Pediatrics - Division Priority List

MD Anderson

Pediatric Clinical Trials

  

Disease Type Phase / Type Title Physician Contact / Phone Protocol Number
phase i / new agent program - Lymphoma  Central Nervous System (CNS)
phase i / new agent program - Lymphoma  Leukemia
phase i / new agent program - Lymphoma  Lymphoma
   I A Phase 1 Study of ADI PEG 20 in Pediatric Subjects Who are Argninosuccinate Synthetase (ASS) Deficient and Have Failed Prior Systemic Therapy Herzog, Cynthia E., M.D. Philip, Ann
(713) 792-6547
2010-0555
Other Divisions' Protocols
   I/II Cord Blood Expansion on Mesenchymal Stem Cells Shpall, Elizabeth, M.D. Main Switchboard
(713) 792-6161
2005-0781
phase i / new agent program - Lymphoma  Melanoma
phase i / new agent program - Lymphoma  Neuroblastoma
phase i / new agent program - Lymphoma  Solid Tumors (non CNS)